1. Riethmuller G, Holz E, Schlimok G, Schmiegel W, Raab R, Hoffken K, et al. Monoclonal antibody therapy for resected Dukes’ C colorectal cancer: seven-year outcome of a multicenter randomized trial. J. Clin. Oncol., 16 (1998) 1788–1794.
2. Gruber R, van Haarlem LJ, Warnaar SO, Holz E, and Riethmuller G. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody C017–1A. Cancer Res., 60 (2000) 1921–1926.
3. Brodsky FM and Guagliardi LD. The cell biology of antigen processing and presentation. Annu. Rev. Immunol., 9 (1991) 707–744.
4. Parham P. Antigen processing. Transporters of delight. Nature (Lond.), 348 (1990) 674–675.
5. Townsend A and Bodmer H. Antigen recognition by class 1 restricted T lymphocytes. Annu. Rev. Immunol., 7 (1989) 601–624.